Supreme Court Reinstates Access to Mifepristone via Telehealth and Pharmacies
In a significant ruling, the Supreme Court has reinstated broad access to the abortion pill mifepristone, countering a previous decision that could have disrupted abortion services nationwide.
On May 4, 2026, the Supreme Court ruled to restore access to mifepristone, allowing it to be obtained through telehealth, mail, and pharmacies. This decision comes in response to a lower court ruling that had threatened to limit access to this critical medication.
The reinstatement of mifepristone access is expected to maintain one of the primary methods of abortion provision in the United States, which has been a contentious issue in recent years.
The court's order will remain in effect until at least May 11, 2026, when further reviews are anticipated. This ruling highlights the ongoing legal battles surrounding reproductive rights and access to healthcare.